Individualized Positive End-expiratory Pressure Guided by End-expiratory Lung Volume in the Acute Respiratory Distress Syndrome (IPERPEEP)
Individualized Positive End-expiRatory Pressure Guided by End-Expiratory Lung Volume in Moderate-to-severe Acute resPiratory Distress Syndrome.The IPERPEEP Study
Sponsor: ClinicalTrialCenter
Terminated
The study was prematurely terminated following the funder's decision to withdraw financial support.
Listed as NCT04012073, this PHASE3 trial focuses on Respiratory Distress Syndrome, Adult and remains terminated or withdrawn. Sponsored by ClinicalTrialCenter, it has been updated 10 times since 2022, reflecting substantial change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
10 versions recorded-
Oct 2025 — Present [monthly]
Terminated PHASE3
Status: Recruiting → Terminated
-
Sep 2024 — Oct 2025 [monthly]
Recruiting PHASE3
-
Jul 2024 — Sep 2024 [monthly]
Recruiting PHASE3
-
Feb 2024 — Jul 2024 [monthly]
Recruiting PHASE3
-
Jan 2023 — Feb 2024 [monthly]
Recruiting PHASE3
Status: Not Yet Recruiting → Recruiting
▶ Show 5 earlier versions
-
Nov 2022 — Jan 2023 [monthly]
Not Yet Recruiting PHASE3
-
Jan 2021 — Nov 2022 [monthly]
Not Yet Recruiting PHASE3
-
Sep 2020 — Jan 2021 [monthly]
Not Yet Recruiting PHASE3
-
Feb 2020 — Sep 2020 [monthly]
Not Yet Recruiting PHASE3
-
Aug 2019 — Feb 2020 [monthly]
Not Yet Recruiting PHASE3
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- ClinicalTrialCenter
- FerrarioDati
- Fondazione Policlinico Universitario Agostino Gemelli IRCCS
- General Electric
For direct contact, visit the study record on ClinicalTrials.gov .